Cargando…

miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL

Pulmonary arterial hypertension (PAH) is a cardiovascular disease that has high incidence and causes massive deaths. miR-155-5p/PYGL pathway was revealed to play a crucial role in PAH by weighted gene co-expression network analysis (WGCNA). The potential mechanism of miR-155-5p in regulating hypoxia...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guowen, Tao, Xuefang, Peng, Linlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275946/
https://www.ncbi.nlm.nih.gov/pubmed/35611851
http://dx.doi.org/10.1080/21655979.2022.2079304
_version_ 1784745603545169920
author Wang, Guowen
Tao, Xuefang
Peng, Linlin
author_facet Wang, Guowen
Tao, Xuefang
Peng, Linlin
author_sort Wang, Guowen
collection PubMed
description Pulmonary arterial hypertension (PAH) is a cardiovascular disease that has high incidence and causes massive deaths. miR-155-5p/PYGL pathway was revealed to play a crucial role in PAH by weighted gene co-expression network analysis (WGCNA). The potential mechanism of miR-155-5p in regulating hypoxia-induced pulmonary artery smooth muscle cell (PASMC) function was analyzed through in vitro experiments. Hypoxia treatment stimulated the proliferation of PASMCs and increased the expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1α (HIF-1α). At the same time, revealed by qRT-PCR and western blot, the level of miR-155-5p was raised, and the level of PYGL was decreased in hypoxia-induced PASMCs. Through CCK-8 assay, transwell assay and flow cytometry, it was revealed that miR-155-5p inhibitor remarkably inhibited the cell proliferation and migration and decreased the proportion of hypoxia-stimulated PASMCs in S and G2/M phases. Dual-luciferase reporter system was subsequently applied to validate the straight regulation of miR-155-5p on PYGL based on the analysis of online database. Furthermore, siPYGL was revealed to reverse the influence of miR-155-5p inhibitor on hypoxia-induced PASMCs. These outcomes indicate that the increased level of miR-155-5p in hypoxia-stimulated PASMCs could enhance the cell proliferation, cell migration, and cell cycle progression by targeting PYGL directly. This study may supply novel treatment strategies for PAH. Abbreviations: PH, pulmonary hypertension; PAH, pulmonary arterial hypertension; WGCNA, weighted gene co-expression network analysis; PASMCs, pulmonary artery smooth muscle cells; VEGF, vascular endothelial growth factor; HIF-1α, hypoxia-inducible factor-1α; SMCs, smooth muscle cells; DEGs, differentially expressed genes; GEO, Gene Expression Omnibus; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; FBS, fetal bovine serum; OD, optical density; BCA, bicinchoninic acid; PVDF, polyvinylidene fluoride; PBS, phosphate-buffered saline; BP, biological process; MF, molecular function; CC, cell component.
format Online
Article
Text
id pubmed-9275946
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-92759462022-07-13 miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL Wang, Guowen Tao, Xuefang Peng, Linlin Bioengineered Research Article Pulmonary arterial hypertension (PAH) is a cardiovascular disease that has high incidence and causes massive deaths. miR-155-5p/PYGL pathway was revealed to play a crucial role in PAH by weighted gene co-expression network analysis (WGCNA). The potential mechanism of miR-155-5p in regulating hypoxia-induced pulmonary artery smooth muscle cell (PASMC) function was analyzed through in vitro experiments. Hypoxia treatment stimulated the proliferation of PASMCs and increased the expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1α (HIF-1α). At the same time, revealed by qRT-PCR and western blot, the level of miR-155-5p was raised, and the level of PYGL was decreased in hypoxia-induced PASMCs. Through CCK-8 assay, transwell assay and flow cytometry, it was revealed that miR-155-5p inhibitor remarkably inhibited the cell proliferation and migration and decreased the proportion of hypoxia-stimulated PASMCs in S and G2/M phases. Dual-luciferase reporter system was subsequently applied to validate the straight regulation of miR-155-5p on PYGL based on the analysis of online database. Furthermore, siPYGL was revealed to reverse the influence of miR-155-5p inhibitor on hypoxia-induced PASMCs. These outcomes indicate that the increased level of miR-155-5p in hypoxia-stimulated PASMCs could enhance the cell proliferation, cell migration, and cell cycle progression by targeting PYGL directly. This study may supply novel treatment strategies for PAH. Abbreviations: PH, pulmonary hypertension; PAH, pulmonary arterial hypertension; WGCNA, weighted gene co-expression network analysis; PASMCs, pulmonary artery smooth muscle cells; VEGF, vascular endothelial growth factor; HIF-1α, hypoxia-inducible factor-1α; SMCs, smooth muscle cells; DEGs, differentially expressed genes; GEO, Gene Expression Omnibus; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; FBS, fetal bovine serum; OD, optical density; BCA, bicinchoninic acid; PVDF, polyvinylidene fluoride; PBS, phosphate-buffered saline; BP, biological process; MF, molecular function; CC, cell component. Taylor & Francis 2022-05-25 /pmc/articles/PMC9275946/ /pubmed/35611851 http://dx.doi.org/10.1080/21655979.2022.2079304 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wang, Guowen
Tao, Xuefang
Peng, Linlin
miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL
title miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL
title_full miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL
title_fullStr miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL
title_full_unstemmed miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL
title_short miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL
title_sort mir-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting pygl
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275946/
https://www.ncbi.nlm.nih.gov/pubmed/35611851
http://dx.doi.org/10.1080/21655979.2022.2079304
work_keys_str_mv AT wangguowen mir1555pregulateshypoxiainducedpulmonaryarterysmoothmusclecellfunctionbytargetingpygl
AT taoxuefang mir1555pregulateshypoxiainducedpulmonaryarterysmoothmusclecellfunctionbytargetingpygl
AT penglinlin mir1555pregulateshypoxiainducedpulmonaryarterysmoothmusclecellfunctionbytargetingpygl